Driving reinvestment in R&D for antibiotics and advocating their responsible use

Defining Responsible Use

There are numerous stakeholder engagement opportunities for individuals and institutions, both public and private, which are involved in antibiotic use, regulation, distribution, research, and the pharmaceutical industry.

Stakeholder input is required for:

– developing a standardized definition of ‘responsible use’,
A modified Delphi RAND procedure involving a large panel of experts and stakeholders will be used to reach consensus on the definition of “responsible antibiotic use” and the associated quality indicators and quantity metrics

– carrying out a barrier analysis for responsible use (COMPLETED), and

– building a conceptual framework for collaboration between public and private sectors (COMPLETED).

 

If you are interested in participating with any of the above, please contact Science Communications Officer Victoria Wells and provide your name, email address, affiliations, and an indication of the capacity in which you would like to get involved.

For more information on the team responsible for these activities, see Work Package 1A: Responsible use of antibiotics, new and old

 

Back to Antimicrobial Use and Stewardship

Back to Stakeholder Engagement